System Guide
Back to Search Results

Search Results

Display Options
Display Options
Select Fields
Export Results to CSV Create Report 0
+ Add all results to report

Report Produced: 05/02/2026 12:41 PM

Report Question ID Question
20130192 MP/H Rules/Histology--Pleura: How is histology coded when the pathology report final diagnosis is "malignant neoplasm, compatible with malignant mesothelioma" if the COMMENT section of the pathology report indicates the tumor has a mixed epithelial and sarcomatoid pattern? See Discussion.
20010124 First Course Treatment: What code is used to represent each treatment modality field when there is no indication that a particular modality of treatment was recommended or started?
20021070 CS Extension/CS Lymph Nodes--Breast: How would you interpret the phrase "axillary lymph node tissue, not clearly a lymph node" or the phrase "satellite nodule of invasive tumor, left axillary lymph node or chest wall tissue"? See discussion.
20120054 Histology/Behavior--Brain and CNS: What is the histology and behavior code for a "giant cell astrocytoma"? See Discussion.
20081028 Multiplicity Counter--Ill-defined sites: How is this field coded for Ill-Defined sites (C760-C768)?
20071096 Multiplicity Counter--Prostate: How is multiplicity counter to be coded for a clinically inapparent prostate cancer for which sextant needle biopsy cores on left and right sides are positive for adenocarcinoma? See Discussion.
20021040 Other Therapy: What code is used to represent treatment with "Epithilone" or "Epothilone"?
20000452 Other Therapy: What code is used to represent "gene" therapy? See discussion.
20031129 Primary Site: How is this field coded for cholangiocarcinoma involving the intrapancreatic bile duct?
20051022 Primary Site--Breast: Would a tumor described as located "lower central" be coded to C501 (central) or C508 overlapping (lower)?